Cafepharma Today

June 12 2025 - BioNTech buys German mRNA vaccine peer CureVac in $1.2B all-stock deal
BioNTech buys German mRNA vaccine peer CureVac in $1.2B all-stock deal
Medtronic recalls ventilators linked to 2 serious injuries, 1 death
Merck aims to plug dengue fever vaccine gap in US
RFK Jr. names some vaccine critics to key CDC committee after ousting entire panel
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Portola: A Small Biotech Stock That Could Double - And Then Double Again
Seeking Alpha
Wednesday, July 2, 2014 - 9:49am
tags:
Portola Pharmaceuticals, Factor Xa inhibition
Is AstraZeneca plc’s Latest Director Deal A Game-Changer?
Motley Fool
Wednesday, July 2, 2014 - 9:45am
tags:
AstraZeneca, Pascal Soriot
Investor Ackman hires Credit Suisse for Allergan bid -source
Yahoo/Reuters
Wednesday, July 2, 2014 - 9:32am
tags:
Bill Ackman, Allergan, Valeant Pharmaceuticals, M&A
Roche to buy U.S. biotech firm Seragon for $725 million
Yahoo/Reuters
Wednesday, July 2, 2014 - 2:45am
tags:
Roche, M&A, Seragon
Allergan readies defense as it fights Valeant for votes
Yahoo/Reuters
Wednesday, July 2, 2014 - 12:02am
tags:
Valeant Pharmaceuticals, Allergan, M&A
Arena Needs To Hold Eisai Accountable For Re-Launch Of Belviq
Seeking Alpha
Wednesday, July 2, 2014 - 12:00am
tags:
Arena Pharmaceuticals, drug launches, Belviq, Eisai
Salix Pharma Hits A New High On Bullish Clinical-Trial Data
Yahoo/Investors Business Daily
Wednesday, July 2, 2014 - 12:00am
tags:
Salix, clinical trials, Xifaxan, IBS-d
ESC Hot Lines: First Real Data On Promising Novartis Heart Failure Drug
Forbes
Tuesday, July 1, 2014 - 11:57pm
tags:
Novartis, LCZ696
Should AstraZeneca Buy MannKind?
Motley Fool
Tuesday, July 1, 2014 - 11:55pm
tags:
MannKind, diabetes, Afrezza, M&A, AstraZeneca
Is this Biogen's Biggest Risk?
Motley Fool
Tuesday, July 1, 2014 - 11:54pm
tags:
Biogen Idec, Tecfidera, MS, multiple sclerosis
First-ever kosher prescription medication
CNBC
Tuesday, July 1, 2014 - 11:53pm
tags:
kosher, Pfizer, Elelyso
Actavis’s Dealmaking New CEO Has ‘Zero Plans’ for Sale
Bloomberg
Tuesday, July 1, 2014 - 1:30pm
tags:
Actavis, M&A, Pharma CEOs, Brent Saunders
Bristol-Myers recalls six lots of blood thinner injection
Yahoo/Reuters
Tuesday, July 1, 2014 - 1:03pm
tags:
blood thinners, recalls, Bristol-Myers Squibb, Coumadin
Will Merck's Anti-PD-1 Therapy be the First to Launch?
Yahoo/Zacks.com
Tuesday, July 1, 2014 - 1:02pm
tags:
Merck, anti-PD-1 immunotherapy, MK-3475
Actavis represents good takeover alternative for Pfizer, says Leerink
Yahoo/Fly on the Wall
Tuesday, July 1, 2014 - 12:23pm
tags:
Pfizer, Actavis, M&A, Forest Labs, AstraZeneca
DEALTALK-Allergan readies defense as it fights Valeant for votes
Reuters
Tuesday, July 1, 2014 - 11:21am
tags:
Allergan, Valeant Pharmaceuticals, M&A
Actavis plc completes Forest Laboratories acquisition
Reuters
Tuesday, July 1, 2014 - 11:19am
tags:
Actavis, Forest Labs, M&A
Sanofi raises stake in Regeneron to 22.5 percent from 20.5 percent
Reuters
Tuesday, July 1, 2014 - 11:17am
tags:
Sanofi, Regeneron
Masimo escapes blood testing patent lawsuit
Mass Device
Tuesday, July 1, 2014 - 11:16am
tags:
Masimo, patents, devices
Did FDA Rely on Exaggerated Numbers to Justify Zohydro?
WSJ Online
Tuesday, July 1, 2014 - 11:11am
tags:
FDA, Zohydro, Zogenix

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Vaccine Advice, Vandalized
In the Pipeline
Novo Nordisk's Canadian Mistake
In the Pipeline
The Bethesda Declaration
In the Pipeline
Taurine and Aging: Is There Anything to It?
In the Pipeline
Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.